Glomerular frontiers: consensus perspectives from @glomcon.org @n0r0zha.bsky.social @poyanmehr.org @bettercallseeth.bsky.social @saynanorouzi.bsky.social #GlomconHawaii 🌊 2025 #NephSky #Nephpearls 👉 link.springer.com/article/10.1...
Fibrillin-1 is a novel ligand of the epidermal growth factor receptor promoting mesangial cell activation and glomerulosclerosis doi.org/10.1016/j.kint.2026.01.018 #MedSky #NephSky #glomerulosclerosis
Clinical Applications of Artificial Intelligence in Autosomal Dominant Polycystic Kidney Disease @ndt-era.bsky.social oup2-idp.sams-sigma.com/authorize?au...
Clinical Applications of Artificial Intelligence in Autosomal Dominant Polycystic Kidney Disease
Abstract. Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disorder leading to kidney failure. Recent advancements in
oup2-idp.sams-sigma.com
New findings suggest a steady increase in the prevalence of kidney failure with replacement therapy worldwide over the past 3 decades. Read more in #ASNKidneyNews kidney.pub/KN1710-24
2025 AJKD Editors' Choice Award winning article: Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study bit.ly/3WeEZ72 #VisualAbstract
📖 This weekend don't miss our @kidneyint.bsky.social #ISNFridaySelection: Patient preferences for kidney failure treatments www.kidney-internati...
Artificial Intelligence in ADPKD: Transforming Diagnosis, Risk Stratification, and Therapeutic Interventions SA-PO0555 : Journal of the American Society of Nephrology #KidneyWk journals.lww.com/jasn/fulltex...
journals.lww.com
Did you know Women in Nephrology offers a Mentor Match program? Whether you want to be a mentor or find one, WIN helps you connect with your perfect match. If you are a member, apply today! #WIN #MentorMatch
Executive summary of the #KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (#IgAN) and Immunoglobulin A Vasculitis (#IgAV) doi.org/10.1016/j.kint.2025.04.003 #OpenAccess #MedSky #NephSky @kdigo.org
Core Curriculum by Craig E. Gordon et al: Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025 bit.ly/465twwK (FREE)
Empowering the Next Generation of Nephrologists: Trainee Opportunities in #GlomCon Ecosystem from @asnpublications.bsky.social @glomcon.org @bettercallseeth.bsky.social @saynanorouzi.bsky.social @nephrologista.bsky.social @poyanmehr.org #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/41105470/
Did you miss #GlomCon Hawaii? Don't worry, I took the hit and flew to Hawaii for a week so I could give all of you a summary of what went down. Read all about it...
Nephrology Times@nephtimes.bsky.social · 10mo agoDON'T MISS Joel Topf's reflections on #GlomConHawaii (plus a few gorgeous photos!). www.docwirenews.com/post/glomcon... @kidneyboy.bsky.social #nephrology #nephsky #glomerulardisease #kidneydisease
Thank you NKF for having us at the #NKFSoCalKidneyWalk 🧡 Today, we hosted a booth to recruit for our “Kidney Check” study, proudly sponsored by the IgAN Foundation.
IgG4-related tubulointerstitial nephritis with negative contrast-enhanced computed tomography: diagnostic insights from 18F-fluorodeoxyglucose–positron emission tomography/computed tomography doi.org/10.1016/j.kint.2025.02.031 #KINephrologyImage #NephSky #MedSky #KidneyPath #RenalPath #kidneybiopsy
ALECT2 amyloidosis in a patient with myeloma cast nephropathy Concomitant renal amyloidosis, typically AL, can be rarely seen in patients with myeloma cast nephropathy. doi.org/10.1016/j.kint.2024.12.024 #NephSky #MedSky #NephrologyImage #renalpath #kidneypath #kidneybiopsy #multiplemyeloma
Artificial intelligence and perspective for rare genetic kidney diseases Chen et al. doi.org/10.1016/j.kint.2025.03.033 #OpenAccess #KIMiniReview #artificialintelligence Find more articles in KI Kidney Genomic Medicine collection: www.kidney-international.org/content/kidn...
Executive summary of the #KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy ( #IgAN) and Immunoglobulin A Vasculitis ( #IgAV) doi.org/10.1016/j.kint.2025.04.003 #OpenAccess #MedSky #NephSky #glomerulardisease @imperialcollegeldn.bsky.social
Is hepatotoxicity still a concern with long-term Tolvaptan use? This #ASNKidney360 review summarizes the data from clinical trials and presents real world evidence: kidney.pub/KID0934
Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy doi.org/10.1016/j.kint.2025.05.028 #OpenAccess #IgAN #felzartamab #IgANephropathy
Cardiovascular Complications in Autosomal Dominant Polycystic Kidney Disease - Kidney International Reports @kireports.bsky.social www.kireports.org/article/S246...
Cardiovascular Complications in Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD), primarily caused by mutations in the PKD1 or PKD2 gene, is among the most common hereditary kidney diseases worldwide and is associated with signi...
kireports.org
Amir Abdipour from #LomaLindaUniversityMedicalCenter discusses his study on the alignment of AI models with nephrologists when answering patient questions about #diabeticnephropathy. Watch now: www.youtube.com/watch?v=yqDP... Read the full article: diabetes.jmir.org/2025/1/e65846/ #AI #LLU
AI vs. Nephrologists: Diabetic Nephropathy Q&A
This video reviews a cross-sectional study comparing how artificial intelligence models like ChatGPT and Google Gemini align with nephrologists when answerin...
youtube.com
Watch this one-minute video highlighting our paper published in @jmirpub.bsky.social www.youtube.com/watch?v=yqDP...
AI vs. Nephrologists: Diabetic Nephropathy Q&A
YouTube video by JMIR Publications
youtube.com
Long-term data presented at #ERA25 on Thursday support the efficacy and safety of zigakibart for IgAN. #nephrology #nephsky #iganephropathy #igan www.docwirenews.com/post/long-te...
Long-Term Data Support Efficacy and Safety of Zigakibart for IgAN | Docwire News
Data from a phase 1/2 study demonstrated that the anti-APRIL zigakibart reduced proteinuria and stabilized kidney function of patients with IgA nephropathy (IgAN) at 100 weeks.
docwirenews.com
Only two weeks left❗️ Mark your calendar ✔️and register today. #EndPKD www.eeds.com/portal_live_...
Portal - Live Events
eeds.com
@n0r0zha.bsky.social · last yr.📣Exciting News! We are thrilled to announce our upcoming Loma Linda Polycystic Kidney Disease Webinar: Expert Insights on Navigating the KDIGO 2025 ADPKD Guidelines. ✅FREE Registration 📅Friday, June 6, 2025 🕥 8:30 AM - 1:00 PM (Pacific Time) 🔗Register here: www.eeds.com/portal_live_...
Real-world challenges in the use of tolvaptan for ADPKD lead to high discontinuation rates and dosage adjustments, underscoring the need for standardized and improved management strategies to enhance tolerability and adherence. https://bit.ly/KID0816 @shelliefravel.bsky.social #ASNKidney360
📣Exciting News! We are thrilled to announce our upcoming Loma Linda Polycystic Kidney Disease Webinar: Expert Insights on Navigating the KDIGO 2025 ADPKD Guidelines. ✅FREE Registration 📅Friday, June 6, 2025 🕥 8:30 AM - 1:00 PM (Pacific Time) 🔗Register here: www.eeds.com/portal_live_...
New JMIR Diabetes: Agreement Between AI and Nephrologists in Addressing Common Patient Questions About Diabetic Nephropathy: Cross-Sectional Study
Agreement Between AI and Nephrologists in Addressing Common Patient Questions About Diabetic Nephropathy: Cross-Sectional Study
Diabetic nephropathy (DN) is one of the most frequent and severe complications of #diabetes mellitus that requires early reduction for the individuals most at risk. Effective intervention and management of DN requires a patient's deep insight and helpful information. Patients require accurate information to obtain prevention advice about their kidney disease to make appropriate decisions; individuals may seek artificial intelligence (AI) as online sources instead of communicating with clinicians. Therefore, to evaluate ChatGPT and Google Bard's capabilities in providing accurate information regarding DN compared to nephrologists, we assessed their performance in answering questions related to DN. Our study revealed AI would not eliminate the need for open and detailed discussion with healthcare professionals regarding medical concerns and treatment plans, as they indicated inconsistencies in responses. Additionally, it is imperative to provide real-time health information updates to meet the needs of individuals with DN.
dlvr.it